NeoGenomics Appoints Warren Stone as CEO, Forecasts $209M Q3 Revenue

Key Facts

1NeoGenomics has appointed Warren Stone as the company's new Chief Executive Officer.

2The company expects to report third-quarter revenue of approximately $209 million.

NeoGenomics has appointed Warren Stone as the company's new Chief Executive Officer and a member of the board. Seeking Alpha reported that the company expects to report third-quarter revenue of approximately $209 million. The leadership change and financial update are part of the company's strategic management transition and quarterly reporting cycle.

NEO closed at $18.47 on October 2, 2026, after reaching a day high of $18.69 and a low of $17.94. The new financial guidance and executive appointment signal stability within the healthcare sector firm's operations.